Table of Contents
India’s Cosmetic and personal care market has grown into one of the most consequential in the Asia-Pacific region — valued at over USD 6 billion and expanding at a compound annual growth rate that consistently outpaces global averages. For a global Cosmetic brand, India is no longer a peripheral market. It is a strategic priority.
Yet for all its commercial appeal, entering India with a Cosmetic product requires clearing a structured regulatory process overseen by the Central Drugs Standard Control Organisation (CDSCO). The cornerstone of that process is the Import Registration Certificate — issued through Form COS-2 following an application in Form COS-1.
This article provides a complete, practitioner-grade walkthrough of that process: who can apply, what documents are required, how the SUGAM portal works, what the statutory timelines look like, and the critical tips that determine whether your application sails through or stalls at the query stage.
Cosmetic imports into India are governed by the Drugs and Cosmetics Act, 1940 and the Cosmetics Rules, 2020 — a significantly modernised framework that replaced the older Drugs and Cosmetics Rules, 1945 provisions relating to Cosmetics. The 2020 Rules streamlined the application process, introduced online filing via the SUGAM portal, and codified timelines for regulatory decision-making.
Under this framework, CDSCO — specifically the Drugs Controller General (India), or DCGI — is the authority that grants import registration certificates for Cosmetics. No Cosmetic product may be imported into India for the purpose of sale or distribution without a valid COS-2 registration certificate.
The Cosmetics Rules 2020 specify four categories of eligible applicants for Cosmetic import registration:
In practice, most global brands entering India for the first time appoint an authorised agent — a company like CliniExperts that holds no commercial interest (no distribution, no marketing, no sales) in the product. This separation of regulatory responsibility from commercial activity is not just a regulatory convenience; it is a compliance requirement Many global brands appoint an authorised agent in India to manage regulatory submissions and liaison with CDSCO
All Cosmetic import registration applications must be submitted through the SUGAM online portal — CDSCO’s centralised digital platform for regulatory submissions. Before any application can be filed, the applicant (whether importer, authorised agent, or manufacturer’s Indian entity) must complete their registration on the SUGAM portal.
Portal registration requires basic entity information, contact details, and the establishment of login credentials. Once registered, the portal enables applicants to initiate new applications, upload supporting documents, pay government fees, and track application status in real time.
A common early mistake is rushing into the application without completing the portal registration properly. An incomplete or incorrectly configured SUGAM account can cause downstream problems at the document upload or fee payment stage, resulting in avoidable delays.
Form COS-1 is the application form through which an applicant seeks an import registration certificate. It is a structured document that captures:
Form COS-1 is generated and filled online through the SUGAM portal. Once all information is entered and required documents are attached, the applicant generates a system-produced COS-1, prints it, obtains the authorised signatory’s signature and company stamp, scans it, and uploads the signed version back into the portal.
This signed COS-1 — along with all supporting documents and the fee payment challan — constitutes the complete application package.
The following documents are mandatory for a COS-2 application:
All documents must be in English. Documents in other languages must be accompanied by a certified English translation.

Fees are paid online through the SUGAM portal. A challan confirming payment — including the amount paid and the applicant’s details — must be generated and uploaded as part of the application. Underpayment is a common cause of deficiency letters and application stalling.
The Cosmetics Rules 2020 stipulate a statutory review timeline of 180 working days from the date of complete and valid application submission. This is the government’s committed processing window for issuing a COS-2 — or raising queries.
In practice, the 180-day clock is reset each time CDSCO raises a query and the applicant provides additional information. It is therefore entirely possible for an application to extend well beyond 180 working days if multiple query rounds occur. This makes front-end application quality — correct categorisation, complete documentation, BIS-compliant formulation — the single most important determinant of actual approval timeline.
An application that is submitted complete and compliant on the first attempt will typically receive its COS-2 registration certificate within 6 to 9 months from the date of filing.
COS-2 is the Import Registration Certificate issued by CDSCO upon successful review and approval of the COS-1 application. It is the document that authorises the holder to import and market the registered Cosmetic product in India.
The COS-2 certificate must be produced by the authorised importer, distributor, or authorised agent as and when required by the licensing authority — at Customs, during market surveillance inspections, or upon request from State Licensing Authorities.
Validity: Five years from the date of issue.
Renewal: The holder must initiate the retention/renewal process well before expiry. (See Article 9 of this series for the complete renewal guide.)
Two Bodies, One Compliance Decision Most global Cosmetic brands entering India are familiar with CDSCO as the gatekeeper for Import registration. Far fewer understand the parallel role of the Bureau o..
For any Foreign Medical Device company seeking to sell its devices in India, obtaining an Import License from CDSCO is a mandatory Regulatory requirement. The two central application forms in this pro..
India’s Emerging Advanced Therapy Landscape Cell and Gene therapies — and chimeric antigen receptor T-cell (CAR-T) therapies in particular — represent one of the most transformative frontier..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)